Change Language
Nitib Ibrutinib 140 Mg Capsules
Nitib Ibrutinib 140 Mg Capsules

Nitib Ibrutinib 140 Mg Capsules

Price 2600 INR/ Unit

MOQ : 10 Units

Nitib Ibrutinib 140 Mg Capsules Specification

  • Dosage Form
  • Capsules
  • Drug Type
  • General Medicines
  • Physical Form
  • Capsules
  • Dosage
  • 140 mg
  • Suitable For
  • Adults
 

Nitib Ibrutinib 140 Mg Capsules Trade Information

  • Minimum Order Quantity
  • 10 Units
  • Supply Ability
  • 1000 Units Per Month
  • Delivery Time
  • 7 Days
 

About Nitib Ibrutinib 140 Mg Capsules

Nitib 140mg Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia)
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Pharmaceutical Capsules Category

Niranib 100mg Cap  (Niraparib Cap)

Niranib 100mg Cap (Niraparib Cap)

Price 38000.0 INR / Unit

Minimum Order Quantity : 1 Unit

Physical Form : Other, Capsule

Salt Composition : Niraparib 100mg

Ingredients : Niraparib Tosylate Monohydrate

Suitable For : Other, Adults only

Lenangio 10 Mg Capsule

Lenangio 10 Mg Capsule

Price 1013 INR / Unit

Minimum Order Quantity : 10 Units

Physical Form : Other, Capsule

Salt Composition : Lenalidomide 10 mg

Ingredients : Lenalidomide

Suitable For : Adults

Mycept-S 360mg (Mycophenolic Acid Delayed-Release Tab USP 360mg)

Mycept-S 360mg (Mycophenolic Acid Delayed-Release Tab USP 360mg)

Price 524.45 INR / Unit

Minimum Order Quantity : 1 Unit

Physical Form : Capsules

Suitable For : Adults

Midostar 25mg Softgel Capsule

Midostar 25mg Softgel Capsule

Price 4394.0 INR / Strip

Minimum Order Quantity : 1 Strip

Physical Form : Capsules

Salt Composition : MIDOSTAURIN25MG

Ingredients : Midostar 25mg Softgel Capsule 28's belongs to the group of medicines called protein kinase inhibitors used to treat acute myeloid leukaemia (AML). It is sometimes, also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SMAHN), or mast cell leukaemia (MCL). Midostar 25mg Softgel Capsule 28's contains Midostaurin, which works by blocking the action of kinase enzymes in abnormal cells and stops their division and growth. Thereby, it helps prevent the spread of cancer and mast cells. Midostar 25mg Softgel Capsule 28's may cause certain side effects such as nausea, vomiting, headache, fever, musculoskeletal pain, and upper abdominal pain. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen. Take Midostar 25mg Softgel Capsule 28's as prescribed by your doctor. Discontinue taking Midostar 25mg Softgel Capsule 28's and inform your physician if you observe any allergic reactions. Inform the doctor about your health condition and medications to rule out any side effects. Do not take Midostar 25mg Softgel Capsule 28's if you are pregnant or breastfeeding. This medicine is not recommended for children as safety and effectiveness have not been established.



Back to top